Intravitreal Bevacizumab for Photodynamic Therapy-Induced Massive Macular Detachment in Acute Central Serous Chorioretinopathy
We present a long followed up case of acute central serous chorioretinopathy (CSC) complicated by a severe visual loss due to massive pigment epithelium detachment of the macula after a full-dose photodynamic therapy (PDT). Rapid anatomical and functional improvement was observed after a single intr...
Main Authors: | Maria G. Kotoula, Fani Zacharaki, Evangelia E. Tsironi |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2012-06-01
|
Series: | Case Reports in Ophthalmology |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/339656 |
Similar Items
-
Hemorrhagic Macular Infarction after Intravitreal Bevacizumab for Chronic Multifocal Central Serous Chorioretinopathy
by: Aditya Kelkar, et al.
Published: (2014-07-01) -
Intravitreal bevacizumab for treatment of central serous chorioretinopathy
by: Cihan Ünlü, et al.
Published: (2016-01-01) -
Changes in the Choroidal Thickness following Intravitreal Bevacizumab Injection in Chronic Central Serous Chorioretinopathy
by: Yoo-Ri Chung, et al.
Published: (2022-06-01) -
Comparison between the functional and anatomical outcomes of full-dose, half-dose photodynamic therapy and intravitreal bevacizumab in chronic central serous chorioretinopathy
by: Abdelrahman G Salman
Published: (2015-01-01) -
Effect of Intravitreal Injection of Bevacizumab on Acute Central Serous Chorioretinopathy Patients who Visited Feiz Hospital during 2014–2015 Period
by: Mohamad Reza Akhlaghi, et al.
Published: (2017-01-01)